Shodhana Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 27.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 23.50 Cr
as on 18-07-2024
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.00 Cr
as on 18-07-2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth 21001.90%
(FY 2023)
- Total Assets 38913.82%
(FY 2023)
About Shodhana Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 27.00 Cr and a paid-up capital of Rs 23.50 Cr.
The company currently has active open charges totaling ₹22.00 Cr.
Giridhar Thota, Rahul Thota, and Nikhil Thota serve as directors at the Company.
- CIN/LLPIN
U24304TG2019PTC131848
- Company No.
131848
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Shodhana Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Giridhar Thota  | Director | 03-Apr-2019 | Current |
| Rahul Thota | Director | 03-Apr-2019 | Current |
| Nikhil Thota | Director | 03-Apr-2019 | Current |
Financial Performance of Shodhana Life Sciences.
Shodhana Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 21001.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shodhana Life Sciences?
In 2023, Shodhana Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shodhana Laboratories Private LimitedActive 24 years 4 monthsRahul Thota and Nikhil Thota are mutual person
Charges (Loans)
₹22.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 22.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 May 2023 | Hdfc Bank Limited | ₹11.00 Cr | Open |
| 27 Mar 2023 | Hdfc Bank Limited | ₹11.00 Cr | Open |
How Many Employees Work at Shodhana Life Sciences?
Unlock and access historical data on people associated with Shodhana Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shodhana Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shodhana Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.